好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

CSF delivery of AAV9-mediated gene therapy for SMA, a lethal neuromuscular disease in children: a dose-response study in mice and nonhuman primates
Neuromuscular and Clinical Neurophysiology (EMG)
P3 - (-)
133
Authors/Disclosures

PRESENTER 		No disclosure on file
No disclosure on file
Sukumar Nagendran, MD No disclosure on file
No disclosure on file
No disclosure on file
Minna Du No disclosure on file
No disclosure on file
Arthur H. Burghes, MD (Ohio State University) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Jerry R. Mendell, MD, FAAN (The Research Institute at Nationwide Children's Hospital) Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
No disclosure on file